CONDITIONS INFLUENCING RELEASE OF GRANULE CONTENTS FROM HUMAN PLATELETS IN CITRATED PLASMA-INDUCED BY ADP OR THE THROMBIN RECEPTOR ACTIVATING PEPTIDE SFLLRN - DIRECT MEASUREMENT OF PERCENT RELEASE OF BETA-THROMBOGLOBULIN AND ASSESSMENT BY FLOW-CYTOMETRY OF P-SELECTIN EXPRESSION
Ml. Rand et al., CONDITIONS INFLUENCING RELEASE OF GRANULE CONTENTS FROM HUMAN PLATELETS IN CITRATED PLASMA-INDUCED BY ADP OR THE THROMBIN RECEPTOR ACTIVATING PEPTIDE SFLLRN - DIRECT MEASUREMENT OF PERCENT RELEASE OF BETA-THROMBOGLOBULIN AND ASSESSMENT BY FLOW-CYTOMETRY OF P-SELECTIN EXPRESSION, American journal of hematology, 52(4), 1996, pp. 288-294
Contrary to a recent report [Rinder et al.: Blood 82:505, 1993], aspir
in does inhibit the release of cu-granule contents as well as inhibiti
ng the release of dense granule contents by human platelets during ADP
-induced aggregation in citrated platelet-rich plasma (PRP). Measureme
nts were: percent release of C-14-serotonin from prelabeled platelets,
radioimmunoassay of beta-thromboglobulin (beta TG), and expression on
the platelet surface of the alpha-granule constituent, P-selectin, by
flow cytometry. During the second phase of ADP-induced aggregation, 6
9.0+/-8.3% of beta TG and 54.1+/-4.6% of C-14-serotonin were released
(means+/-SEM, n=13); aspirin treatment reduced these values to 6.0+/-1
.2 and 1.0+/-0.3%, respectively. In contrast, incubation of platelets
with ADP without stirring caused only 6.7+/-1.7% release of beta TG an
d 2.1+/-0.4% release of C-14-serotonin; these low values were not appr
eciably affected by aspirin. During ADP-induced primary aggregation in
PRP anticoagulated with FPRCH(2)Cl (PPACK), only 4.7+/-0.9% release o
f beta TG and no detectable release of C-14-serotonin occurred; aspiri
n had no effect. In both stirred and unstirred PRP, the thrombin recep
tor activating peptide, SFLLRN (50 mu M), caused at least 75% release
of the contents of both granules, which was partially inhibited by asp
irin. Upon incubation of platelets with ADP (2-10 mu M), the mean fluo
rescence intensity due to P-selectin was <14% of that induced by SFLLR
N. In this unstirred system used for flow cytometry, aspirin treatment
caused no significant inhibition of P-selectin expression, Thus, unde
r conditions in which ADP does not cause secondary aggregation (physio
logical Ca2+ concentration or unstirred citrated PRP) release of the c
ontents of both types of granules is less than 7% and aspirin is not i
nhibitory; the P-selectin expression associated with this low percent
release is also unaffected by aspirin. However, aspirin does strongly
inhibit the extensive release of both alpha-granule and dense granule
contents during ADP-induced secondary aggregation in citrated PRP. (C)
1996 Wiley-Liss, Inc.